ESSA Pharma Inc. (NASDAQ:EPIX – Get Free Report) (TSE:EPI)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.44 and traded as high as $6.85. ESSA Pharma shares last traded at $6.05, with a volume of 181,690 shares trading hands.
ESSA Pharma Price Performance
The stock has a market capitalization of $268.40 million, a P/E ratio of -9.60 and a beta of 1.84. The firm’s 50 day moving average price is $5.44 and its 200 day moving average price is $6.31.
ESSA Pharma (NASDAQ:EPIX – Get Free Report) (TSE:EPI) last issued its quarterly earnings data on Monday, August 5th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.10. On average, equities research analysts forecast that ESSA Pharma Inc. will post -0.71 earnings per share for the current year.
Hedge Funds Weigh In On ESSA Pharma
ESSA Pharma Company Profile
ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.
Further Reading
- Five stocks we like better than ESSA Pharma
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- How Much Can You Make in Stocks in One Month?
- Pros And Cons Of Monthly Dividend Stocks
- This Is the Top Large-Cap Stock Insiders Are Buying
- Health Care Stocks Explained: Why You Might Want to Invest
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.